Biotransformation of 3,-acetoxy-19-hydroxycholest-5-ene 6 g) by Moraxella sp. was studied. Estrone (712 mg) was the major metabolite formed. Minor metabolites identified were 5a-androst-1-en-19-ol-3,17-dione (33 mg), androst-4-en-19-ol-3,17-dione (58 mg), androst-4-en-9a,19-diol-3,17-dione (12 mg), and androstan-19-ol-3,17-dione (1 mg). Acidic metabolites were not formed. Time course experiments on the fermentation of 19-HCA indicated that androst-4-en-19-ol-3,17-dione was the major metabolite formed during the early stages of incubation. However, with continuing fermentation its level dropped, with a concomitant increase in estrone. Fermentation of 19-HCA in the presence of specific inhibitors or performing the fermentation for a shorter period (48 h) did not result in the formation of acidic metabolites. Resting-cell experiments carried out with 19-HCA (200 mg) in the presence of a,a'-bipyridyl led to the isolation of three additional metabolites, viz., cholestan-19-ol-3-one (2 mg), cholest-4-en-19-ol-3-one (10 mg), and cholest-5-en3jS,19-diol (12 mg). Similar results were also obtained when n-propanol was used instead of a,o'-bipyridyl. Resting cells grown on 19-HCA readily converted both 5G-androst-1-en-19-ol-3,17-dione and androst-4-en-19-ol-3,17-dione into estrone. Partially purified 1,2-dehydrogenase from steroid-induced Moraxella cells transformed androst-4-en-19-ol-3,17-dione into estrone and formaldehyde in the presence of phenazine methosulfate, an artificial electron acceptor. These results suggest that the degradation of the hydrocarbon side chain of 19-HCA does not proceed via C22 phenolic acid intermediates and complete removal of the C17 side chain takes place prior to the aromatization of the A ring in estrone. The mode of degradation of the sterol side chain appears to be through the fission of the C17-C20 bond. On the basis of these observations, a new pathway for the formation of estrone from 19-HCA in Moraxella sp. has been proposed.
ol-3,17-dione into estrone. Partially purified 1,2-dehydrogenase from steroid-induced Moraxella cells transformed androst-4-en-19-ol-3,17-dione into estrone and formaldehyde in the presence of phenazine methosulfate, an artificial electron acceptor. These results suggest that the degradation of the hydrocarbon side chain of 19-HCA does not proceed via C22 phenolic acid intermediates and complete removal of the C17 side chain takes place prior to the aromatization of the A ring in estrone. The mode of degradation of the sterol side chain appears to be through the fission of the C17-C20 bond. On the basis of these observations, a new pathway for the formation of estrone from 19-HCA in Moraxella sp. has been proposed.
Cholesterol and phytosterols have long been considered potential starting materials for the microbial production of steroid hormones. Studies pertaining to microbial degradation of the hydrocarbon side chain of various sterols have been comprehensively documented (1, 2, 6, 16, 18, 19, (22) (23) (24) 26) . It was demonstrated that prior to side-chain cleavage in sterols, the organism initially oxidizes the A ring to a 4-en-3-one structure. At this stage, the organism carries out the oxidation of the terminal methyl group of the side chain, followed by ,B-oxidation. Thus, the hydrocarbon side chain is degraded via C26, C24, and C22 acids to Cl9 androstane derivatives. These studies have clearly established that the acidic intermediates play an important role in the microbial conversion of sterols to 17-keto steroids (1, 6, 16, 18, 19, (22) (23) (24) 26) . Studies have also shown that microbes are able to metabolize the bulkier side chain of 1-sitosterol in a manner analogous to cholesterol degradation (18, 19) .
Sterol-degrading microorganisms are generally known to possess both side chain-and steroid nucleus-degrading activities (16) . The nucleus-degrading activity can be prevented either by using specific inhibitor or by chemically modifying the substrate (16) . Modified sterols such as cholest-4-en-19-ol-3-one and 3p-acetoxy-19-hydroxycholest 5-ene (19-HCA) have been shown to be converted into estrone microbiologically (22) (23) (24) . These studies have clearly demonstrated that the degradation of the C17 side chain proceeds via C22 phenolic acid intermediates (22) (23) (24) . The three-carbon side chain of C22 phenolic acid is cleaved to estrone and propionic acid, suggest- ing that the complete removal of the C17 side chain takes place only after the aromatization of the A ring (22) (23) (24) .
During our attempts to develop a microbial process to selectively eliminate the C17 side chain of cholesterol or its derivatives, a soil microorganism belonging to the genus Moraxella was isolated by an enrichment culture technique using a model compound isooctylcyclopentane as the sole source of carbon (2, 11) . The organism also accepted cholesterol and 19-HCA (metabolite I) as the sole source of carbon. Earlier, it was shown that this organism converts 19-HCA (I) into estrone (II) (2) . However, attempts were not made to establish the degradative sequence in the conversion of I into II.
The present study was initiated to gain information regarding the aromatization of the A ring with the steroid nucleus intact and cleavage of the C17 side chain. We report here the isolation and identification of neutral metabolites from 19-HCA and propose a new pathway for the microbial conversion of 19-HCA (I) into estrone (II) without the involvement of C22 phenolic acid intermediates. The neutral metabolites III, IV, V, VI, VII, and IX have never been shown as metabolites derived from 19-HCA (I), and among them III appears to be hitherto unknown.
MATERUILS AND METHODS
Materials. 19-HCA (I) was synthesized by following the procedure of Kalvoda et al. (10) . Cholesterol, androst-4-en-19-ol-3,17-dione (IV) and ot,a'-bipyridyl (ox,ot'-D) were procured from Sigma Chemical Co. (St. Louis, Mo.). All reference steroids were 100% pure as judged by thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC).
Methods. Infrared (IR) spectra, UV spectra, nuclear magnetic resonance (NMR) spectra, and mass spectra (MS) were obtained as described previously (17 105 ,000 x g for 2 h, and the supernatant (650 mg) was applied to a DEAE-cellulose column (3 by 12 cm) previously equilibrated with 0.03 M Tris-HCl buffer (pH 7.5) containing 10% glycerol (buffer A). After the column was washed with buffer A (500 ml), it was successively eluted with buffer A containing 0.1 M KCl (250 ml) and 0.2 M KCl (250 ml). The 0.2 M KCl eluate contained most of the 1,2-dehydrogenase activity. This fraction, upon concentration by ultrafiltration (P-10 membrane) and dialyzing (10 to 12 h) against buffer A, yielded nearly sevenfold purified enzyme (60 mg).
Enzyme assay. 1,2-Dehydrogenase activity was determined by measuring the rate of 2,6-dichlorophenol-indophenol (DCIP) reduction at 600 nm in a mixture consisting of phosphate buffer (0.03 M, pH 7.5), enzyme (1 mg), phenazine methosulfate (0.4 ,umol), DCIP (0.45 ,umol), and progesterone (1.2 ,umol in 6 ,ul of acetone) in a total volume of 3 ml. The reaction was initiated by the addition of substrate (progesterone). The reduction of DCIP was measured using an extinction coefficient of 21 x 103 M-t cm-' (25) . The enzyme readily converts progesterone to 1,2-dehydroprogesterone. The protein determinations were made by the method of Lowry et al. (12) .
Conversion of androst-4-en-19-ol-3,17-dione (IV) to estrone (II) by 1,2-dehydrogenase. Partially purified enzyme (50 mg) was incubated with IV (16.5 pumol) and phenazine methosulfate (20 pumol) From this, 0.5 ml was used for the oxygen uptake studies. 6-Methylheptan-2-one (25 ,ug in 5 ,ul of acetone) was used as the substrate. The reaction mixture consisted of 1.5 ml of Tris buffer (0.03 M, pH 7.2) and 0.5 ml of the cell suspension. After the endogenous oxygen consumption was complete, the reaction was initiated with the addition of 6-methylheptan-2-one.
RESULTS

Metabolism of 19-HCA (I).
A batch of 120 flasks containing 19-HCA (0.05%) was inoculated with Moraxella cells, and at the end of the incubation period, the contents were pooled and processed as described above. The crude neutral fraction (4.8 g) was subjected to column chromatography on silica gel ( requires M+ 302.1882. On the basis of spectral analyses, compound A was identified as androst-1-en-19-ol-3,17-dione (III). The ring junction between A and B was established as trans by X-ray analysis (X-ray data will be published elsewhere). Thus the compound was identified as 5ot-androst-1-en-19-ol-3,17-dione (Fig. 1, III) . Compound III appears to be hitherto unknown.
Compound B. Recrystallization of this compound (from MeOH) gave white crystals (58 mg) with an mp of 168 to 1690C. This was identified as androst-4-en-19-ol-3,17-dione (Fig. 1, IV) by comparison (IR, NMR, MS, and HPLC) with the authentic sample. The melting point of IV is the same as that reported for androst-4-en-19-ol-3,17-dione (3).
Compound C. Recrystallization of this compound (from MeOH) gave white crystals (12 The 'H NMR spectrum of this compound is similar to that of androst-4-en-19-ol-3,17-dione (IV). However, both IR spectral and MS analyses indicated the presence of one more hydroxyl than in compound IV. The proton NMR pattern suggests that the second hydroxyl is tertiary in nature and the possible positions are 8,B, 9a, and 14ot. The absence of deshielding of 18-CH3 protons rules out the possibility of a hydroxyl group at position 14ot. So, the logical conclusion is that the hydroxyl group may be at either the 83 or 9a position. X-ray analysis of compound C conclusively established that the position of the tertiary hydroxyl is at 9cx (5). Hence, metabolite C was identified as androst-4-en-9ot,19-diol-3,17-dione (Fig. 1, V) The 'H NMR spectrum of this compound showed the absence of an olefinic proton (no signal between 5 and 7.5 8). The MS analysis suggested that the molecular weight is two units higher than that of compound IV. On the basis of these observations, compound D was tentatively identified as androstan-19-ol-3,17-dione (Fig. 1, VI) . Because of the paucity of the material, further analysis could not be carried out to confirm the structure assigned.
The time course plot (Fig. 2) on the fermentation of 19-HCA (I) carried out for a period of 7 days indicated that during the early stages of incubation (2 days), very little 19-HCA was metabolized (ca. 10%) and among the metabolites formed only androst-4-en-19-ol-3,17-dione (IV) was present in detectable amounts. However, prolonging the incubation period to 3 days resulted in the accumulation of IV (ca. 80% of the total metabolites formed, as judged by HPLC analyses) and low levels of estrone (II). When the fermentation was continued beyond 3 days and up to 7 days, the level of IV dropped gradually (Fig. 2) , with a concomitant increase in II. In fact, at the end of 7 days, estrone (II) was the major metabolite formed and it was noticed that nearly 40% of the added 19-HCA (I) was utilized during this period (determined by the amount of unreacted 19-HCA recovered at the end of 7 days). The presence of metabolites III and V could be seen only after 3 days in small quantities (together constituting nearly 10% of the total metabolites formed; data not shown).
Metabolism of 19-HCA (I) in the presence of inhibitors. Fermentation was carried out in the presence of inhibitors as described above. TLC analysis of the neutral fractions obtained when o,a'-D and n-propanol were used as inhibitors revealed the presence of not only estrone (II) and androst-4-en-19-ol-3,17-dione (IV) but also three additional metabolites, E (Rf 0.33, system II), F (Rf 0.19, system II), and G (Rf 0.07, system II), which were not noticed when the fermentation was carried out without the inhibitors. Acidic metabolites were not formed even in the presence of inhibitors. The HPLC profile of the neutral fraction indicated that a,a'-D inhibited the formation of androst-4-en-9ot,19-diol-3,17-dione (V), whereas its presence was seen at low levels when n-propanol was used as the inhibitor. It is interesting that higher levels of metabolites E, F, and G were formed when resting cells were incubated with 19-HCA in the presence of x,a'-D. The (Fig. 1, VIII) Fig. 3 . Incubation carried out in the absence of inhibitors clearly indicated (Fig. 3a) that during the early stages (12 h), cholest-4-en-19-ol-3-one (VIII) was the major metabolite formed, whereas the levels of estrone (II) and androst-4-en-19-ol-3,17-dione (IV) were comparatively lower. However, by prolonging the incubation period to 24 and 48 h, the levels of VIII dropped significantly with a concomitant increase in II and IV. During this period, a considerable amount of androst-4-en9a,19-diol-3,17-dione (V) was formed (Fig. 3a) . and II and IV were present at extremely low levels (Fig. 3b) . Similar results were also noticed when n-propanol was used instead of o,a'-D, although cholest-4-en-19-ol-3-one (VIII) was present at comparatively lower levels. Besides, n-propanol did not completely inhibit the formation of V, and levels of II and IV were higher than those in the experiment with c,ct'-D.
Hence, a large-scale experiment was carried out with a,oa'-D to isolate VIII.
Transformation of androst-4-en-19-ol-3,17-dione (IV) with resting cells. Transformation products formed at different time intervals (12, 24 , and 48 h) were analyzed by HPLC (Fig. 4a) . It was noticed that the level of androst-4-en-19-ol-3,17-dione (IV) dropped gradually, with a concomitant increase in the level of estrone, and at the end of 24 h, nearly 80% of IV was converted into estrone (II). During this period, androst-4-en9ox,19-diol-3,19-dione (V) was formed at low levels (10 to 15% of the total product formed). A similar experiment carried out using androst-1-en-19-ol-3,17-dione (III) as the substrate also indicated its conversion to estrone (II) (Fig. 4b) . However, the rate of conversion of III to II was considerably slower than the rate of conversion of IV to II. In fact, after 24 h, nearly 40% of III was converted into estrone (II).
Metabolism of androst-4-en-19-ol-3,17-dione (IV) in vitro. Partially purified 1,2-dehydrogenase was incubated with androst-4-en-19-ol-3,17-dione (IV) in the presence of phenazine methosulfate, as described above. One half of the assay mixture when extracted with methylene chloride yielded an enzymatic product (Rf 0.67, system I), purified by preparative thin-layer chromatography (system I) and identified as estrone (II) on the basis of NMR, MS, and HPLC analyses. To the other half of the assay mixture, 2,4-dinitrophenylhydrazine reagent was added and the hydrazone derivative formed was purified and identified as that of formaldehyde by comparison of the mass spectrum with that of the chemically prepared sample.
Manometric studies. Manometric studies using 6-methylheptan-2-one were carried out as described above. (Fig. 1 ) different from that established earlier (22) (23) (24) . The degradation of the hydrocarbon side chain of 19-HCA (I) does not appear to proceed via C22 acid intermediates. Cursory examination of all the metabolites formed from 19-HCA (I) and time course experiments provide information regarding the sequence of reactions taking place during the formation of estrone (II) and suggest that aromatization of the A ring in II takes place only after the cleavage of the C17 side chain. The time course study on the fermentation of 19-HCA (I) (Fig. 2 ) and resting-cell experiments carried out with androst-4-en-19-ol-3,17-dione (IV) (Fig. 4a) clearly indicate the precursorproduct relationship between metabolites IV and II. 5ot-Androst-1-en-19-ol-3,17-dione (III) and androst-4-en-9cx,19-diol-3,17-dione (V) were formed only in small quantities, and at no time did they constitute more than 10% of the total metabolites formed. The cell extract prepared from steroidinduced cells contained higher levels of steroid 1,2-dehydrogenase than 4,5-dehydrogenase. The specific activities of the 1,2-dehydrogenase and 4,5-dehydrogenase were 3.143 and 0.667 nmol/min/mg, respectively. So, it appears that the major Our studies carried out with Moraxella sp. appear to differ from those reported earlier (24) , where it was demonstrated that the microbial degradation of cholest-4-en-19-ol-3-one (VIII) into estrone (II) proceeds via C22 phenolic acid intermediates. In that case, the three-carbon side chain of the C22 phenolic acid is cleaved to estrone (II) and propionic acid, suggesting that the complete removal of the C17 side chain takes place only after the aromatization of the A ring (24) . Similar observations were also made by Arima et al. (1) , noting that a species of Nocardia produces pregna-1,4-dien-3-one-20-carboxylic acid during the fermentation of cholesterol in the presence of ot,ot'-D. Further, it was established that the degradation of the side chain involves carbon-carbon bond fission at C24-C25, C22-C23, and C17-C20, resulting in the formation of 17-keto steroid (18) . The mode of degradation of the hydrocarbon side chain of cholesterol in the microbial system differs from that of the mammalian system, which involves the cleavage of the C20-C22 and C17-C20 bonds (21) . Our results appear to be different from either of these two modes of fission. We were not able to demonstrate the formation of acidic metabolites from 19-HCA (I) when the transformation was carried out in the presence of specific inhibitors or for a shorter duration, suggesting that acidic intermediates are not involved in the degradative sequence. So, it is quite possible that Moraxella sp. carries out the direct cleavage of the side chain of cholest-4-en-19-ol-3-one (VIII) between C17 and C20 to yield androst-4-en-19-ol-3,17-dione (IV) and 6-methylheptan-2-one. Our efforts to isolate 6-methylheptan-2-one from the incubation mixture consisting of 19-HCA (I) and resting cells were not successful. Interestingly, we have noticed that cells adapted to 19-HCA readily metabolize 6-methylheptan-2-one and the manometric studies with 6-methylheptan-2-one confirmed this observation. Earlier, Horvath and Kramli reported the isolation of 6-methylheptan-2-one after incubating cholesterol with Azotobacter sp., suggesting the fission of the side chain is between C17 and C20 (7).
The hitherto unknown 5a-androst-1-en-19-ol-3,17-dione (III) could have been formed from cholestan-19-ol-3-one (VII). Earlier, workers from our laboratory showed that sidechain cleavage takes place independently even when the A ring is blocked (2) . Hence, side-chain cleavage can take place even in the absence of a 3-keto-4-en system. It is reasonable to assume that the fission of the side chain in VII takes place between C17 and C20, in a manner analogous to the side-chain cleavage of cholest-4-en-19-ol-3-one (VIII), yielding androstan-19-ol-3,17-dione (VI). 1,2-Dehydrogenation of metabolite VI results in the formation of neutral metabolite III (Fig. 1) . In fact, earlier it was demonstrated that S5t-androstan-3,17-dione was 1,2-dehydrogenated by Corynebacterium simplex, indicating that the dehydrogenase does not have any rigid requirement for a 4-en-3-one structure (27) .
Many investigators have used inhibitors to enable detection of intermediary metabolites (18, 19) . The addition of chelating agents such as a,ot'-D to cholesterol-decomposing microorganisms not only inhibits the 9oa-hydroxylation reaction, but also induces the accumulation of acidic intermediates. In this study, it was observed that incubation carried out in the presence of a,xa'-D or n-propanol did not result in the formation of acidic metabolites. However, a,a'-D completely inhibited 9a-hydroxylation when resting cells were incubated with 19-HCA (I) (Fig. 3) . Besides, metabolite (VIII) was formed in appreciable amounts (Fig. 3) . Similarly, the accumulation of cholest-4-en-3-one in the medium was observed during the microbial degradation of cholesterol in the presence of ot,a'-D or n-propanol (18) .
It appears that the pathway (Fig. 1) 
